Abstract
Machine learning has been more and more widely used in the medical field in recent years, and new advances have been made in the diagnosis and treatment of breast cancer, diabetic retinopathy, neuropsychiatric diseases, and atherosclerosis. Machine learning is showing great potential in the diagnosis and prediction of liver diseases. With reference to patients' serological markers and imaging findings, the model established based on machine learning for the diagnosis and prediction of hepatitis B virus (HBV)-related liver diseases has been widely recognized. This article introduces the application, current status, advantages, and advances of machine learning in HBV-related liver diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
